[1]JournalofMedicinalChemistry,1997,vol.40,p.1075-1089
[2]Patent:US6046212,2000,A
[3]Patent:WO2012/110860,2012,A1.Locationinpatent:Page/Pagecolumn75-76
[1]Patent:WO2007/42321,2007,A2.Locationinpatent:Page/Pagecolumn48-49
22890-53-5
610-92-4
636-94-2
586-30-1
619-12-5
51572-88-4
1007488-29-0 | (1-Ethyl-1h-pyrazol-5-yl)methanol | AA00921U | MFCD08701089
1185298-02-5 | 3-(2,5-Difluorophenoxy)pyrrolidine hydrochloride | AA0092DM | MFCD09879248
1206982-50-4 | 2-Ethyl-5-oxazolemethanamine | AA0092QL | MFCD16300702
1070892-90-8 | methyl 4-chloro-2-methoxy-5-(tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate | AA0093HJ | MFCD19441823
1117843-17-0 | 4-Chloro-2-MethylbenzaMide | AA0093WJ | MFCD12922943
1049727-56-1 | (3S,4R)-4-(4-Fluorophenyl)pyrrolidine-3-carboxylic acid hydrochloride | AA00943P | MFCD06659259
1033132-02-3 | 1-Propyl-3-(trifluoromethyl)pyrazole | AA00947I | MFCD16619915
1203499-48-2 | 2-Amino-6-methyl-1,8-naphthyridine-3-carbonitrile | AA0094EY | MFCD13563080
1209173-54-5 | (1-(3-Chlorophenyl)cyclopropyl)methanamine hydrochloride | AA0094PS | MFCD09864779
1132093-70-9 | Dasatinib-d8 | AA00956U | MFCD15071210